Karmanos Cancer Institute Announces Interim Leadership
“Dr. Schwartz is an excellent choice to lead us during this period of transition,” said
Having rejoined the Karmanos faculty 10 years ago, Dr. Schwartz, who is unrelated to
Previous to this appointment, Dr. Schwartz served as the Associate Center Director for Population Sciences at Karmanos since 2002. Her research focuses on the genetics underlying lung cancer risk. She has an M.S. in Biology from
Dr. Schwartz’ first faculty appointment was with the Michigan Cancer Foundation in 1986. She spent 1991-1999 at the
As Interim Chief Operating Officer, Broughton’s main responsibilities include the smooth and efficient operation of the Karmanos Cancer Center to ensure the delivery of high quality care at the hospital and all of the Karmanos clinical operations while continuing their profitability.
Broughton served on both Karmanos boards through
He is also a Fellow in the American College of Healthcare Executives and a Fellow in the Hospital Financial Management Association.
“Ann will work directly with
“I am delighted that
“The faculty and staff of the
“I have worked with Ann for more than six years. She is an exemplary researcher who is dedicated to finding a cure for this insidious disease. She is a strong leader and will serve the Institute well during this transition,” said
Karmanos board leadership has worked closely with
About The Barbara Ann Karmanos Cancer Institute
Located in mid-town
SOURCE Barbara Ann Karmanos Cancer Institute